MedTrace Logo

A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD

NCT00182260 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2012-11-15

No results posted yet for this study

Summary

LNF is an effective intervention in the management of patients with chronic GERD requiring maintenance therapy. LNF is cost-effective compared with long-term medical therapy.

LNF is more effective than maximum medical therapy in control of respiratory symptoms and complications of GERD.

Conditions

  • Gastroesophageal Reflux

Interventions

DRUG

Proton Pump Inhibitors

PROCEDURE

Laparoscopic Nissen Fundoplication

Sponsors & Collaborators

Principal Investigators

  • Mehran Anvari, MB, BS, PhD · McMaster University

  • David Armstrong, MB, BCh, MA · McMaster University

  • Charles H. Goldsmith, PhD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-01-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182260 on ClinicalTrials.gov